Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2025-12-25 @ 2:22 AM
NCT ID:
NCT02598934
Eligibility Criteria:
Inclusion Criteria:
* Women newly diagnosed with postmenopausal osteoporosis
* Naive to prior bisphosphonate therapy
Exclusion Criteria:
* Inability to stand or sit upright for at least 60 minutes
* Inability to swallow a tablet whole
* Hypersensitivity to any component of ibandronate
* Hormone (estrogen) replacement therapy within last 3 months, or will start on therapy within next 6 months
* Other osteoporosis drug within last 3 months
* Malignant disease diagnosed within previous 10 years, except resected basal cell cancer
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT02598934
Study Brief:
Protocol Section:
NCT02598934